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ABSTRACT 
 
The aim of the present study was to evaluate the antidiabetic activity of Ipomoea staphylina (IS) leaves in 
Streptozotocin (STZ)-nicotinamide induced type-II diabetic in rats. Oral administration of ethanolic extract of IS 
leaves and its fractions at the doses of 100 mg/kg and 200 mg/kg was studied in glucose-loaded and STZ-
nicotinamide  induced diabetic rats. The effects of extract and its fractions on blood glucose, body weight, lipid 
profile, plasma enzymes (SGOT, SGPT and ALP), serum urea, creatinine, total protein, liver glycogen, and 
activities of SOD, CAT and GPx in diabetic rats were analyzed. The IS extract and its fractions significantly reduced 
the blood glucose level in glucose-loaded rats. After treatment with IS extract and its fractions (100 and 200 mg/kg) 
for 21 days there was a significant decrease in blood glucose, total cholesterol, triglycerides, LDL-C, VLDL-C, 
plasma enzymes (SGOT, SGPT and ALP), serum urea, creatinine and significant increase in body weight and total 
protein levels was observed in treated diabetic rats. The activities of antioxidant enzymes SOD, CAT and GPx were 
also inceased in diabetic mice after the treatment with IS extract and its fractions. Histological analysis showed 
improvement in the cellular architecture of pancreas, liver and kidney.  
Key words: Antidiabetic, Ipomoea staphylina (IS), streptozotocin (STZ), nicotinamide, body weight, blood glucose, 
total cholesterol, triglycerides,creatinine 
Introduction 
Diabetes Mellitus (DM) is one of the most prevalent 
metabolic disorders characterized with increased blood 
sugar level and improper primary metabolism. It is 
characterized by alterations in the metabolism of 
carbohydrate, fat and protein, which are caused by a 
inappropriate secretion of insulin or insulin resistance 
or both [1]. Hyperglycemia lead to decrease in the 
number of glucose transporters and down-regulation of 
number of insulin receptors as well as defects of tissue 
insulin signal transduction. In addition, increase in the 
hepatic glucose output, which exceeds an increase of 
glucose utilization. Finally, the hyperglycemia 
condition manifest adverse effects on β-cell insulin 
secretion and thus insulin resistance occur [2-3]. The  
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number of people with diabetes is increasing due to 
population growth, aging, urbanization and increasing 
prevalence of obesity and physical inactivity. 
According to recent estimate, the greatest absolute 
increase in the number of people with diabetes will be 
in India and the total number of people with diabetes is 
projected to 79.4 million in 2030.It is expected that 
about 366 million people are likely to be diabetic by 
the year 2030 [4]. Many antidiabetic drugs are 
available for long term therapy are found to be 
associated with various toxicities and none of them 
gives long duration glycaemic control without causing 
any adverse side effects. Thus there is a growing 
interest in using natural plant sources having minimal 
side effects for the treatment of DM [5].Ipomoea 
staphylina (IS) is commonly found on hedges and 
bushes in the forests and waste lands. It is a perennial, 
woody and glabrous shrub with pink flowers. 
Traditionally Ipomoea staphylina is used for 
respiratory disorders. Traditionally genus Ipomoea is 
used as [6] purgative, dyspepsia, anthelmintic, 
bronchitis. A literature review reveals anti-
inflammatory activity, 5-lipoxygenase, α-glucosidase 
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and [6, 7] α-amylase inhibitory activity of Ipomoea 
staphylina. Bioactive chemical constituents reported 
from the leaves of Ipomoea staphylina [6] include 
Sitosteryl-3-O-β-D-glucoside and chiro deoxy inositol. 
Hence, the present study was aim evaluate the 
antidiabetic activitiy of Ipomoea staphylina leaves on 
streptozotocin-nicotinamide induced type-II diabetic in 
rats. 
Materials and methods 
Drugs and chemicals 
STZ was procured from Hi- Media India, 
glibenclamide were obtained from Aventis Pharma, 
India. Total cholesterol, triglycerides, SGOT, SGPT, 
ALP, total protein, serum urea and creatinine kits were 
obtained from Span Diagnostics, India. All other 
chemicals chemicals were commercial products of 
analytical reagent grade.  
Collection of plant material and extraction 
Leaves of IS were collected from forest area of 
Karnataka near to Bangalore. The Ipomoea staphylina 
plant taxonomically identified and authenticated by Dr. 
K. Karthigeyan at Central National Herbarium, Botanic 
Garden, Howrah, where the voucher specimen is 
conserved under the reference number SMF-01.  
The leaves of IS were cleaned and dried under shade at 
room temperature for several days and powdered. The 
powder was defatted with petroleum ether (60-80 GR) 
for 72 h and then the dried powder was extracted with 
ethyl alcohol to get a yield of 10.2 % w/w. The 
ethanolic extract was dispersed in distilled water and 
partitioned with ethyl acetate in a separating funnel till 
the colourless ethyl acetate fraction is obtained. Then 
the aqueous part is then partitioned with n-butanol to 
get the butanol fraction. Ethyl acetate and n-butanol 
fraction so obtained was concentrated by keeping in 
boiling water bath to get the solid residue. The dried 
extract and its fractions were stored in airtight 
container and placed in refrigerator [8]. 
Preliminary phytochemical screening 
Preliminary phytochemical screening of ethanolic 
extract of IS leaves and its ethyl acetate and n-butanol 
fractions were performed for the presence of alkaloids, 
phenolics, flavonoids, saponins, proteins, 
carbohydrates and glycosides [9]. 
 
Animals 
Healthy adult male Wistar Albino rats weighing 180-
220 g maintained under controlled conditions of 
temperature (23±2°C) and humidity (50±5%) and a 12h 
light–dark cycle, were used for the experiment. They 
were housed in sanitised polypropylene cages 
containing sterile paddy husk as bedding. They had 
free access to standard rat pellet diet and water ad 
libitum. The animals were given a week's time to get 
acclimatized with the laboratory conditions. All the 
experimental procedures were performed according to 
the committee for the purpose of control and 
supervision of experiments on animals (CPCSEA), 
ministry of social justice and empowerment 
Government of India, norms and approved by the 
Institutional Animal Ethics Committee (IAEC). 
Acute toxicity studies  
Mice were kept overnight fasting prior to drug 
administration. Animals were received a single oral 
dose (2000 mg/kg, b.w.) of ethanolic extract of leaves 
of IS and its ethyl acetate and n-butanol fractions. After 
the administration of Ipomoea staphylina leaves extract 
and its fractions food was withheld for further 3-4 h. 
Animals were observed individually at least once 
during the first 30 min after dosing, periodically during 
the first 24 h (with special attention during the first 4 h) 
and daily thereafter for a period of 14 days. Once daily 
cage side observations included changes in skin and 
fur, eyes and mucous membrane (nasal) and also 
respiratory rate, circulatory (heart rate and blood 
pressure), autonomic (salivation, lacrimation, 
perspiration, piloerection, urinary incontinence, and 
defecation) and central nervous system (ptosis, 
drowsiness, gait, tremors and convulsion) changes. 
Mortality, if any, was determined over a period of 2 
weeks [10]. 
Oral Glucose Tolerance Test (OGTT) 
Oral glucose tolerance test was performed in overnight 
fasted normal rats to assess the glucose tolerance. Rats 
were divided into eight groups of six each. Group I: 
Normal control rats were treated with vehicle (2.5 
ml/kg of saline) alone; Group II: Rats were treated with 
treated with glibenclamide (10 mg/kg); Group III: Rats 
were treated with IS extract (200 mg/kg); Group IV: 
Rats were treated with IS extract (100 mg/kg); Group 
V: Rats were treated with ethyl acetate fraction of IS 
extract (200 mg/kg); Group VI: Rats were treated with 
ethyl acetate fraction of IS extract (100 mg/kg); Group 
VII: Rats were treated with n-butanol fraction of IS 
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extract (200 mg/kg); Group VIII: Rats were treated 
with n-butanol fraction of IS extract (100 
mg/kg).Overnight fasted rats were fed glucose (2 g/kg) 
30 min after the administration of extract and its 
fractions and and glibenclamide blood was collected at 
0, 30, 60 and 120 min interval from orbital sinus for 
glucose estimation
 
[11]. 
Induction of diabetes and experimental design 
Diabetes was induced in overnight fasted rats by single 
intraperitoneal injection of STZ (50 mg/kg), freshly 
dissolved in 0.1 M cold citrate buffer, pH 4.5 15 min 
after the intraperitoneal administration of nicotinamide 
(120 mg/kg). After a week in time for the development 
and aggravation of diabetes, rats with moderate 
diabetes (i.e. blood glucose concentration, >250 mg/dl) 
that exhibited glycosuria and hyperglycemia were 
selected for the experiment. The animals were 
randomly assigned into nine groups of six animals in 
each group and received the following treatments: 
Group I: Normal control rats treated with vehicle (2 % 
gum acacia, 5 ml/kg/day) alone; Group II: Diabetic 
control rats treated with vehicle alone; Group III: 
Diabetic rats treated with glibenclamide (10 mg/kg); 
Group IV: Diabetic rats treated with IS Extract (200 
mg/kg); Group V: Diabetic rats treated with ethyl 
acetate extract (100 mg/kg); Group VI: Diabetic rats 
treated with ethyl acetate fraction of IS extract (200 
mg/kg); Group VII: Diabetic rats treated with ethyl 
acetate fraction of IS extract (100 mg/kg); Group VIII: 
Diabetic rats treated with n-butanol fraction of IS 
extract (200 mg/kg); Group IX: Diabetic rats treated 
with n-butanol fraction of IS extract (100 mg/kg) [12, 
13]. Treatment was given orally using an intragastric 
tube once daily for 21 days, continuously. On 21
st
 day, 
the animals were fasted for 12 h, blood was drawn 
from retro orbital vein under mild ether anaesthesia for 
various biochemical estimations. The animals were 
sacrificed by cervical decapitation. Liver and kidneys 
were dissected out, immediately rinsed in ice cold 
saline and stored for further biochemical estimations. 
Changes in the body weight were also determined at 0, 
7
th
, 14
th
 and 21
st
 day. 
Biochemical analysis 
Serum glucose was measured by using a glucometer 
(Accu-Chek Active, India). Serum total cholesterol, 
total triglyceride, LDL-c, VLDL-c and HDL-c were 
estimated using standard Enzymatic (Span Diagnostics, 
India). The estimation of SGOT, SGPT , serum ALP, 
total protein, serum urea, and creatinine was done by 
using standard Enzymatic (Span Diagnostics, India). 
The liver and kidney homogenate, prepared in ice 
chilled 10% potassium chloride solution, was used to 
measure the levels and activities of lipid peroxidation 
(LPO), superoxide dismutase (SOD), catalase (CAT) 
and glutathione peroxidase (GPx). 
Histopathological studies 
Pancreas, liver and kidneys were instantly dissected 
out, excised and rinsed in icecold saline solution. A 
portion of liver and kidney were fixed in 10% neutral 
formalin fixative solution, were fixed in 10% formalin, 
dehydrated in alcohol and then embedded in paraffin. 
Microtome sections of 4–5 µm thickness were made by 
using a rotary microtome. The sections were stained 
with haematoxylin–eosin (H&E) dye to observe 
histopathological changes [14]. 
Statistical analysis 
Results were expressed Mean ± SEM from six animals 
in each group. Comparison between the groups were 
made by using one way analysis of variance 
(ANOVA), followed by Tukey-Kramer Multiple 
Comparisons Test with the help of INSTAT software. 
p<0.05 was considered as statistically significant.  
Results 
Acute oral toxicity 
In LD50 studies, it was found that the animals were 
safe up to a maximum dose of 2000 mg/kg body 
weight. There were no changes in normal behavior 
pattern and no signs and symptoms of toxicity and 
mortality were observed. The biological evaluation was 
carried out at doses of 100 and 200 mg/kg body weight. 
Effect of Ipomoea staphylina on oral glucose 
tolerance test (OGTT) in rats 
After glucose loading, it was observed that normal 
control rats showed higher blood glucose level. 
Administration of ethanolic extract of IS leaves and its 
fractions (100 and 200 mg/kg, p.o.) significantly 
(p<0.001) lower the blood glucose levels at 30 mins 
and 60 mins as compared to normal control rats. The 
ethanolic extract of IS leaves (200 mg/kg, p.o.) also 
significantly reduced the blood glucose level at 120 
mins. The ethyl acetate fraction (200 mg/kg, p.o.) also 
found to reduce the blood glucose level at 120 mins 
(Figure 1).  
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Figure 1: Effect of IS extract and its fractions on oral glucose tolerance test (OGTT) in rats 
Effect of IS extract and its fractions on blood glucose level in STZ-nicotinamide induced diabetic rats 
Figure 2 shows the effect of ethanolic extract of IS its 
ethyl acetate and n-butanol fractions on blood glucose 
levels of diabetic rats. It was found that a significant 
(p<0.001) increase in blood glucose level was observed 
in STZ-nicotinamide induced diabetic rats. After the 
daily treatment for 21 days showed significant 
(p<0.001) reduce in blood glucose levels with the doses 
of 100 and 200 mg/kg, p.o. of ethanolic extract of IS 
and its fractions and 10 mg/kg, p.o. of glibenclamide as 
compared to diabetic control group. 
 
Figure 2: Effect of IS extract and its fractions extract and its fractions on blood glucose level in STZ-
nicotinamide induced diabetic rats 
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Effect of IS extract and its fractions on body weight in STZ-nicotinamide induced diabetic rats 
Average body weights of different animal groups at 
various intervals are shown in table 1. STZ-
niconinamide induce diabetic produced significant 
(p<0.001) loss in body weight as compared to normal 
animals during the study. Diabetic control continued to 
lose weight till the end of the study while 
Glinbenclamide (10 mg/kg, p.o.) and ethanolic extract 
of IS and its ethyl acetate and n-butanol fractions (100 
and 200 mg/kg, p.o.) showed significant (p<0.001) 
improvement in body weight compared to diabetic 
control at 21
st
 days. 
 
Table 1: Effect of IS extract and its fractions on body weight in STZ-nicotinamide induced diabetic rats 
 
Groups 
 
 
Treatment 
Body Weight (gm) 
0 day 7th day 14th day 21st  day 
I Normal control 167.02± 
2.90 
176.10± 
3.26 
189.85± 
2.25 
192.28± 
1.48 
II Diabetic control 
 
168.27± 
1.89 
152.22± 
2.00
### 
147.43± 
1.93
### 
140.26± 
1.94
### 
III Glinbenclamide (10 
mg/kg) 
168.22± 
2.38 
173.52± 
1.01
*** 
178.39± 
1.28
*** 
180.75± 
1.13
*** 
IV IS Extract 
(200mg/kg) 
167.68± 
2.56 
170.93± 
1.84
*** 
174.75± 
2.13
*** 
179.75± 
1.11
*** 
V IS Extract 
(100mg/kg) 
164.53± 
2.22 
167.90± 
1.34
*** 
170.25± 
1.21
*** 
174.02± 
1.93
*** 
VI Ethyl acetate 
fraction of IS 
(200mg/kg) 
170.53± 
1.79 
175.04± 
1.34
*** 
178.15± 
1.25
*** 
181.25± 
1.72
*** 
VII Ethyl acetate 
fraction of IS 
(100mg/kg) 
165.21± 
2.24 
168.31± 
2.00
*** 
170.90± 
1.02
*** 
170.87± 
2.09
*** 
VIIII n-Butanol fraction 
of IS 
(200mg/kg) 
165.80± 
1.73 
167.79± 
1.42
*** 
170.11± 
1.40
*** 
172.03± 
1.95
*** 
IX n-Butanol fraction 
of  IS(100mg/kg) 
166.58± 
1.44 
166.20± 
1.02
*** 
168.34± 
1.54
*** 
169.23± 
1.48
*** 
 
Values are given as mean ± SEM for groups of six animals each  
### 
p <0 .001 when compared with the normal control group 
***
p <0 .001 when compared with the diabetic control group 
 
Effect of IS extract and its fractions on lipid profile in STZ-nicotinamide induced diabetic rats 
STZ-nicotinamide treatment resulted in significant 
(p<0.001) increase of TC, TG, LDL-C, VLDL-C and 
reduction of HDL-C levels as compared to the normal 
control rats. Treatment with ethanolic extract of IS and 
its ethyl acetate and n-butanol fractions (100 and 200 
mg/kg, p.o.) showed significant (p<0.001) reduction in 
TC and TG. The extract and its fraction (100 and 200 
mg/kg, p.o.) also significantly reduced the LDL-C and 
VLDL-C level compared to diabetic control.  HDL-C 
level was increased significantly by the ethanolic 
extract of IS and its ethyl acetate fraction (200 mg/kg, 
p.o.). The n-butanol fraction increased the HDL-C 
level but not in a significant manner (Table 2). 
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Table 2: Effect of IS extract and its fractions on lipid profile in STZ-nicotinamide induced diabetic rats 
 
Groups 
 
 
Treatment 
 
Lipid parameters (mg/dl) 
TC TG HDL -C LDL-C VLDL-C 
I Normal control 73.10± 
1.82 
84.84± 
2.66 
34.72± 
1.38 
21.40±1.2
8 
16.96± 
0.53 
II Diabetic control 
 
147.6± 
 2.63### 
173.8± 
3.19### 
16.21± 
1.00### 
96.63±2.9
8### 
34.77± 
0.63### 
III Glinbenclamide 
(10mg/kg) 
87.42± 
2.23*** 
97.10±2.10*
** 
29.94± 
2.08*** 
38.05±1.5
0*** 
19.48± 
0.39*** 
IV IS Extract 
(200mg/kg) 
100.08± 
2.47*** 
113.4± 
2.26*** 
28.72± 
1.73*** 
48.65±3.2
7*** 
22.68± 
0.45*** 
V IS Extract 
(100mg/kg) 
125.89± 
2.13*** 
142.54± 
2.26*** 
22.37± 
1.71 
75.00±2.0
8*** 
28.50± 
0.45*** 
VI Ethyl acetate fraction 
of IS 
(200mg/kg) 
113.18± 
2.41*** 
121.04± 
1.39*** 
25.03± 
1.01** 
63.93±2.5
6*** 
24.20± 
0.27*** 
VII Ethyl acetate fraction 
of IS 
(100mg/kg) 
131.81± 
3.29*** 
151.15± 
1.65*** 
20.40± 
1.04 
81.17±2.5
2** 
30.02± 
0.49*** 
VIIII n-Butanol fraction of 
IS(200mg/kg) 
121.23± 
1.65*** 
130.95± 
2.50*** 
22.11± 
1.17 
72.92±2.5
2*** 
26.18± 
0.50*** 
IX n-Butanol fraction of 
IS(100mg/kg) 
134.99± 
2.08* 
154.47± 
1.16*** 
18.98± 
1.28 
85.10±0.9
8* 
30.89± 
0.23*** 
Values are given as mean ± SEM for groups of six animals each  
### 
p <0 .001 when compared with the normal control group 
***
p <0 .001, 
**
p <0 .01 and 
*
p <0 .05 when compared with the diabetic control group 
 
Effect of IS extract and its fractions on SGOT, SGPT and ALP level in STZ-nicotinamide induced diabetic 
rats
In STZ-nicotinamide induced diabetic rats a significant 
increase in activities of SGOT, SGPT and ALP was 
observed. After treatment with ethanolic extract of IS and 
its ethyl acetate and n-butanol fraction (100 and 200 
mg/kg, p.o.) the SGOT, SGPT and ALP activities were 
significantly reduced compared to diabetic rats (Table 3). 
The effect of ethanolic extract of IS and its ethyl acetate 
fraction (200 mg/kg) on SGOT, SGPT and ALP activities 
were more significant (p<0.001).  
 
Table 3: Effect of IS extract and its fractions on SGOT, SGPT and ALP level in STZ-nicotinamide induced 
diabetic rats 
Groups Treatment SGOT (U/L) 
 
SGPT (U/L) 
 
ALP (mg/dl) 
I Normal control 81.10±2.05 62.38±2.65 113.34±2.57 
II Diabetic control 138.54±3.11### 110.4±3.56### 196.81±3.13### 
III Glinbenclamide (10mg/kg) 90.75±2.14*** 76.76±3.29*** 135.09±1.57*** 
IV IS Extract (200mg/kg) 97.14±1.66*** 82.13±3.38*** 140.51±2.65*** 
V IS Extract (100mg/kg) 120.28±3.05*** 91.96±2.17*** 161.29±2.84*** 
VI Ethyl acetate fraction of IS 
(200mg/kg) 
107.17±2.40*** 88.92±1.86*** 148.06±2.04*** 
VII Ethyl acetate fraction of IS(100mg/kg) 124.29±1.96** 100.53±2.59 176.56±1.72*** 
VIIII n-Butanol fraction of IS(200mg/kg) 120.26±2.13*** 94.27±1.50** 169.62±2.42*** 
IX n-Butanol fraction of IS 
(100mg/kg) 
131.45±2.92 99.32±3.18 180.98±2.67** 
Values are given as mean ± SEM for groups of six animals each  
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### 
p <0 .001 when compared with the normal control group 
***
p <0 .001 and
 **
p <0 .01 when compared with the diabetic control group 
 
Effect of IS extract and its fractions on serum creatinine, blood urea, blood urea nitrogen and total protein 
level in STZ-nicotinamide induced diabetic rats 
 
The effect of ethanolic extract of IS and its ethyl 
acetate and n-butanol fractions (100 and 200 mg/kg, 
p.o.) on serum creatinine, blood urea, blood urea 
nitrogen (BUN) and total protein level in STZ-
nicotinamide induced diabetic rats is shown in table 4. 
In diabetic rats a significant (p<0.001) increase in the 
levels of serum creatinine, blood urea and blood urea 
nitrogen was observed when compared to normal rats. 
Diabetic rats treated with ethanolic extract of IS and its 
fractions (100 and 200 mg/kg, p.o.) showed significant 
(p<0.001) reduction in the levels of serum creatinine 
level when compared with diabetic rats. Blood urea and 
blood urea nitrogen (BUN) were also significantly 
reduced by the ethanolic extract of IS and its ethyl 
acetate fraction (200 mg/kg, p.o.) when compared with 
diabetic rats. Diabetic rats showed a significant 
(p<0.001) decrease in serum total protein which was 
increased significantly with treatment of ethanolic 
extract of IS and its fractions. 
 
Table 4: Effect of IS extract and its fractions on serum creatinine, blood urea, blood urea nitrogen and total 
protein level in STZ-nicotinamide induced diabetic rats 
Groups 
 
Treatment Serum 
Creatinine  
(mg/dL) 
 
Blood Urea 
(mg/dL) 
Blood Urea 
Nitrogen 
(mg/dl) 
Total 
Protein 
(g/dl) 
I Normal control 0.64± 
0.02 
30.70± 
1.69 
14.33± 
0.79 
6.86± 
0.11 
II Diabetic control 
 
2.04± 
0.03
### 
50.26± 
2.74
### 
23.46± 
1.28
### 
3.06± 
0.10
### 
III Glinbenclamide (10 
mg/kg) 
0.81± 
0.02
*** 
34.29± 
2.31
*** 
15.77± 
1.01
*** 
5.34± 
0.14
*** 
IV IS Extract 
(200 mg/kg) 
0.89± 
0.02
*** 
37.39± 
2.42
** 
17.46± 
1.13
** 
5.15± 
0.09
*** 
V IS Extract 
(100 mg/kg) 
1.32± 
0.01
*** 
40.64± 
2.17 
18.97± 
1.01 
4.37± 
0.14
*** 
VI Ethyl acetate 
fraction of IS 
(200 mg/kg) 
0.97± 
0.02
*** 
34.49± 
1.70
* 
17.97± 
0.79
* 
4.93± 
0.08
*** 
VII Ethyl acetate 
fraction of IS 
(100 mg/kg) 
1.41± 
0.02
*** 
42.33± 
1.52 
19.76± 
0.74 
4.19± 
0.06
*** 
VIII n-Butanol fraction 
of IS 
(200 mg/kg) 
1.18± 
0.03
*** 
40.66± 
2.03 
18.98± 
0.95 
4.41± 
0.10
*** 
IX n-Butanol fraction 
of IS 
(100 mg/kg) 
1.46± 
0.03
*** 
44.71± 
2.51 
20.87± 
0.95 
3.82± 
0.05
*** 
 
Values are given as mean ± SEM for groups of six animals each  
### 
p <0 .001 when compared with the normal control group 
***
p <0 .001, 
**
p <0 .01 and 
*
p <0 .05 when compared with the diabetic control group 
 
 
 
Asian Pac. J. Health Sci., 2016; 3 (3):30-44                                             e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Firdous and Singh                  ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(3): 30-44 
www.apjhs.com      37 
 
Changes in hepatic LPO, GPx, CAT and SOD of normal and STZ-nicotinamide induced diabetic rats after 21 
days of treatment with IS extract and its fractions  
In diabetic rats, a significant (p<0.001) rise in the 
activity of LPO was observed in the liver. Treatment 
with ethanolic extract of IS and its ethyl acetate and n-
butanol fractions (200 mg/kg, p.o.) showed significant 
decrease in liver LPO level. The activities of GPx, 
CAT and SOD level in liver were also significantly 
decrease (p<0.001) in diabetic rats. Treatment with the 
ethanolic extract of IS and its fractions were 
significantly increased the liver GPx and CAT level. 
The extract and its ethyl acetate fraction but not n-
butanol fraction was found to increase the SOD level in 
the liver (Table 5). 
Table 5: Changes in hepatic LPO, GPx, CAT and SOD of STZ-nicotinamide induced diabetic rats after 21 
days of treatment with IS extract and its fractions 
Groups 
 
Treatment LPO (ηm of 
MDA / mg of 
protein) 
GPx (μMole of 
the oxidise 
GSH/min/mg of 
protein) 
Catalase (μm 
H2O2/mg 
of protein) 
SOD (U/mg of 
protein) 
I Normal control 9.85±1.03 15.85±0.87 13.16±0.89 16.62±0.66 
II Diabetic control 38.10±1.63### 6.53±1.06### 5.60±0.60### 7.13±0.58### 
III Glinbenclamide 
(10 mg/kg) 
16.28±1.08
*** 13.02±1.19*** 12.03±1.05*** 13.47±0.84*** 
IV IS Extract 
(200mg/kg) 
20.81±1.30
*** 12.26±0.99** 11.29±0.78** 12.05±0.68*** 
V IS Extract 
(100mg/kg) 
29.75±1.58
** 8.84±0.86 8.33±0.96 9.64±0.62 
VI Ethyl acetate 
fraction of IS 
(200mg/kg) 
25.16±1.33
*** 10.34±1.11 10.35±1.09* 11.37±1.05** 
VII Ethyl acetate 
fraction of IS 
(100mg/kg) 
28.93±1.07
*** 8.64±0.77 8.06±0.90 8.30±0.65 
VIII n-Butanol fraction 
of IS 
(200mg/kg) 
27.23±1.62
*** 9.68±0.62 9.80±0.53* 9.93±0.58 
IX n-Butanol fraction 
of IS 
(100mg/kg) 
31.72±1.25
* 8.20±0.81 7.39±0.64 7.97±0.70 
 
Values are given as mean ± SEM for groups of six animals each  
### 
p <0 .001 when compared with the normal control group 
***
p <0 .001, 
**
p <0 .01 and 
*
p <0 .05 when compared with the diabetic control group 
 
Changes in kidney LPO, GPx, CAT and SOD of normal and STZ-incotinamide induced diabetic rats after 21 
days of treatment with IS extract and its fractions     
Table 6 shows the activities of LPO, GPx, CAT and 
SOD in the kidney of normal and diabetic rats. A 
significant (p<0.001) increase in the activity of LOP 
and reduction in the activities of GPx, CAT and SOD 
were seen in diabetic rats. Treatment with ethanolic 
extract of IS and its ethyl acetate and n-butanol 
fractions (100 and 200 mg/kg, p.o.) significantly 
(p<0.001) lowered the LOP level. The ethanolic extract 
of IS and its ethyl acetate fraction significantly 
increased the GPx, CAT and SOD levels. But the n-
butanol fraction failed to show significant increase in 
GPx, CAT and SOD levels. 
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Table 6: Changes in kidney LPO, GPx, CAT and SOD of STZ-nicotinamide induced diabetic rats after 21 
days of treatment with IS extract and its fractions 
 
Groups 
 
Treatment LPO (ηm of 
MDA / mg 
of protein) 
GPx (μMole of 
the oxidise 
GSH/min/mg of 
protein) 
Catalase (μm 
H2O2/mg of 
protein) 
SOD (U/mg 
of protein) 
I Normal control 12.04±1.09 11.03±1.10 15.64±0.96 13.86±1.04 
II Diabetic control 41.03±1.80### 4.85±0.83### 7.03±0.82### 7.16±0.61##
# 
III Glinbenclamide (10 
mg/kg) 
13.82±1.16
*** 9.78±1.03** 13.92±0.81*** 12.21±0.70*
** 
IV IS Extract(200mg/kg) 19.22±1.15*** 9.32±1.24** 12.67±1.12*** 11.98±0.79*
* 
V IS Extract (100mg/kg) 25.73±0.89*** 6.12±0.56 9.37±0.78 9.07±0.81 
VI Ethyl acetate fraction of 
IS (200mg/kg) 
22.27±1.38
*** 8.61±0.72* 13.04±0.99*** 10.72±0.84* 
VII Ethyl acetate fraction of 
IS(100mg/kg) 
28.33±1.40
*** 5.61±0.38 8.07±0.61 8.82±0.56 
VIII n-Butanol fraction of 
IS(200mg/kg) 
25.78±0.67
*** 6.86±0.46 9.83±0.80 8.87±0.74 
IX n-Butanol fraction of IS 
(100mg/kg) 
30.53±1.02
*** 5.08±0.40 7.42±0.67 7.73±0.43 
 
Values are given as mean ± SEM for groups of six animals each  
### 
p <0 .001 when compared with the normal control group 
***
p <0 .001, 
**
p <0 .01 and 
*
p <0 .05 when compared with the diabetic control group 
 
Effect of IS on serum insulin level in STZ-nicotinamide induced diabetic rats 
 
In STZ-nicotinamide induced diabetic rats the serum 
level of insulin was significantly decreased. Treatment 
with the ethanolic extract of IS and its ethyl acetate and 
n-butanol fractions (100 and 200 mg/kg, p.o.) for 21 
days increased the serum level of insulin significantly 
(Figure 3).  
 
Figure 3: Effect of Ipomoea staphylina (IS) extract and its fractions on serum insulin in STZ-nicotinamide 
induced diabetic rats 
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Effect of ethanolic extract of leaves of IS and its fractions on histopathological analysis of pancreas, liver and 
kidney 
The section of pancreas of normal control rats showed 
normal pancreatic acini and islets of langerhans. The 
section of pancreas of STZ-nicotinamide induced 
diabetic rats showed atrophy, degenerative changes in 
pancreatic acini, infiltration of inflammatory cells and 
loss of cells in islets of langerhans. Diabetic rats treated 
with glibenclamide (10 mg/kg, p.o.) and the extract of 
leaves of IS and its fractions (200 mg/kg, p.o.) showed 
almost normal cellular architecture with less atrophy, 
degenerative changes in pancreatic acini, infiltration of 
inflammatory cells and less loss of cells in islets of 
langerhans (Figure 4). The liver of the STZ-
nicotinamide induced induced diabetic rats showed 
hypertrophy of hepatocytes, kupffer cells, 
hepatocellular necrosis and vacuolization with loss of 
nuclei. Diabetic rats treated with glibenclamide (10 
mg/kg, p.o.) and the extract of leaves of IS and its 
fractions (200 mg/kg, p.o.) showed an improvement of 
the hepatoellular architecture with normal nucleus and 
cytoplasm with less necrosis of hepatocytes (Figure 
5).The kidney of normal control rats in STZ-
nicotinamide induced diabetic model showed the intact 
tubules and glomeruli whereas STZ-nicotinamide 
induced induced diabetic rats was found to cause 
degenerating tubules with desquamated epithelial cells 
in the lumen, misshapen tubules, tubulitis and 
glomerular congestion. Diabetic rats treated with 
glibenclamide (10 mg/kg, p.o.) and the extract of 
leaves of IS and its fractions (200 mg/kg, p.o.) showed 
the almost normal cellular architecture with intact 
tubules and glomeruli (Figure 6).  
 
 
 
 
 
Figure 4: Histology of pancreas in STZ-nicotinamide induced diabetic rats after 21 days of treatment 
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(A) Normal control, (B) Diabetic control, (C) Diabetic+Glinbenclamide (10 mg/kg, p.o.), (D) Diabetic+IS extract 
(200 mg/kg, p.o.), (E) Diabetic+IS extract (100 mg/kg, p.o.), (F) Diabetic+Ethyl acetate fraction of IS extract (200 
mg/kg, p.o.), (G) Diabetic+Ethyl acetate fraction of IS extract (100 mg/kg, p.o.), (H) Diabetic+n-bulanol fraction of 
IS extract (200 mg/kg, p.o.) and (I) Diabetic+ n-butanol fraction of IS extract (100 mg/kg, p.o.) 
 
 
 
 
 
Figure 5: Histology of liver in experimental STZ-nicotinamide induced diabetic rats after 21 days of 
treatment 
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(A) Normal control, (B) Diabetic control, (C) Diabetic+Glinbenclamide (10 mg/kg, p.o.), (D) Diabetic+IS extract 
(200 mg/kg, p.o.), (E) Diabetic+IS extract (100 mg/kg, p.o.), (F) Diabetic+Ethyl acetate fraction of IS extract (200 
mg/kg, p.o.), (G) Diabetic+Ethyl acetate fraction of IS extract (100 mg/kg, p.o.), (H) Diabetic+n-bulanol fraction of 
IS extract (200 mg/kg, p.o.) and (I) Diabetic+ n-butanol fraction of IS extract (100 mg/kg, p.o.) 
 
 
 
 
Figure 6: Histology of kidney in STZ-nicotinamide induced diabetic rats after 21 days of treatment 
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(A) Normal control, (B) Diabetic control, (C) Diabetic+Glinbenclamide (10 mg/kg, p.o.), (D) Diabetic+IS extract 
(200 mg/kg, p.o.), (E) Diabetic+IS extract (100 mg/kg, p.o.), (F) Diabetic+Ethyl acetate fraction of IS extract (200 
mg/kg, p.o.), (G) Diabetic+Ethyl acetate fraction of IS extract (100 mg/kg, p.o.), (H) Diabetic+n-bulanol fraction of 
IS extract (200 mg/kg, p.o.) and (I) Diabetic+ n-butanol fraction of IS extract (100 mg/kg, p.o.) 
Discussion 
Streptozotocin (STZ) is 1-methyl-l-nitrosourea 
attached to the carbon-2 position of glucose that causes 
β-cell necrosis and induces experimental diabetes in 
many animal models. It causes DNA strand breaks that 
induce the activation of poly-ADP-ribose synthetase 
followed by lethal nicotinamide adenine dinucleotide 
(NAD) depletion [15]. Nicotinamide dinucleotide (NA) 
causes activation of the poly ADP ribose synthase to 
repair the damaged DNA and protecting the decrease in 
the level of NAD and proinsulin thereby partially 
reversing the inhibition of insulin secretion to prevent 
the aggravation of experimental diabetes [16, 17]. This 
condition shows a number of features which are similar 
with type 2 diabetic mellitus (T2DM). Hence, based on 
this point of view, the hypoglycaemic activity of 
ethanolic extracts IS and its fractions were carried out 
on glucose-loaded hyperglycemic and streptozotocin-
nicotinamide induced type 2 diabetic rats. In the 
present study, the IS extracts and its fractions showed 
significant decrease in blood glucose various intervals 
in oral glucose tolerance test (OGTT).  In 
streptozotocin-nicotinamide induced type 2 diabetic 
mellitus, oral administration of ethanolic extract of IS 
and its fractions for 21 days showed a significant 
reduction in blood glucose level. The possible 
mechanim by which the extract and its fractions 
reduced the blood glucose level in diabetic rats might 
be due to stimulation of surviving β-cells leading to 
increase in insulin secretion. Decrease in body weight 
in streptozotocin-nicotinamide induced type 2 diabetic 
rats was observed during the study. This notable 
decrease in the body weight in diabetic rats might be 
because of protein wasting or degradation of structural 
proteins. The loss of protein is probably due to the 
unavailability of carbohydrates for energy metabolism 
[18]. Diabetic rats treated with ethanolic extract of IS 
and its fractions showed an improvement in body 
weight as compared to the diabetic control rats which 
may be due to its protective effect in controlling 
muscle wasting i.e. reversal of gluconeogenesis.In 
diabetes mellitus a reflective changes in the serum 
cholestrol, triglycerides and lipoprotein occur which 
increase the risk of coronary heart disease [19]. 
Diabetic rats were treated with ethanolic extract of IS 
and its fractions showed reduction in the level of total 
cholesterol, triglycerides, LDL-C and VLDL-C and 
improved the level of HDL-C. From this study, we can 
conclusively state that the ethanolic extract of IS and 
its fractions could modulate blood lipid abnormalities. 
It is hypothesized that increase in SGOT, SGPT and 
ALP are predictors of diabetes. Increased activities of 
SGOT, SGPT and ALP are a common sign of liver 
disease. In streptozotocin-nicotinamide induced type 2 
diabetic, rats increase in serum SGOT, SGPT and ALP 
level may be due to the leakage of these enzymes from 
liver cytosol into blood stream as a result of the 
hepatotoxic effect of STZ (20). Treatment with 
ethanolic extract of IS and its fractions decreased the 
levels of SGOT, SGPT and ALP in diabetic animals, 
which indicates that the extract tends to prevent liver 
damage in diabetes by maintaining integrity of plasma 
membrane, thereby suppressing the leakage of enzymes 
through membrane.Insulin deprivation in diabetic state 
causes a profound increase in protein catabolism. In 
this present study, fall in plasma total protein and rise 
in serum urea, creatinine and blood urea nitrogen 
(BUN) levels were observed in diabetic rats. Urea and 
creatinine in the serum are significant markers to detect 
the renal dysfunction, might be due to increased protein 
catabolism in the body. Accumulation of urea nitrogen 
in experimental diabetes may due to the enhanced 
breakdown of both liver and plasma proteins [20]. The 
decrease in serum urea and creatinine levels on 
treatment with ethanolic extract of IS and its fractions 
indicated that the extract and its fractions prevented the 
progression of renal damage in diabetic rats.Generation 
of free radicals in diabetes mellitus reacts with lipids 
causing lipid peroxidation, resulting in the release of 
products such as malondialdehyde, hydroperoxide and 
hydroxyl radicals. The oxidative stress in diabetes 
decreases the antioxidant status. SOD, CAT and GPx 
are enzymatic antioxidants plays an important role in 
protecting cells from being exposed to oxidative 
damage by direct elimination of reactive oxygen 
species (ROS). They reduce superoxide anion (O2
.─
) 
and hydrogen peroxide generation which further reduce 
the generation of hydroxyl radicals and thus, reduce the 
initiation and propagation of lipid peroxidation and 
decrease the LPO level [21]. Treatment with ethanolic 
extract of IS and its fractions significantly reduced 
levels of lipid peroxidation in liver and kidney and 
increased the activity of SOD, CAT and GPx in both 
liver and kidney. STZ causes diabetes by the rapid 
depletion of β-cells and thereby brings about a 
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reduction in insulin release. Reduced (or absent) 
secretion of insulin, often coupled with reduced 
sensitivity to its action causes diabetes mellitus [22]. In 
streptozotocin-nicotinamide induced type 2 diabetic 
rats decrease in serum insulin was observed. Treatment 
with ethanolic extract of IS and its fractions 
significantly improved the serum level of insulin. The 
histology study of pancreas showed atrophy, 
degenerative changes in pancreatic acini, infiltration of 
inflammatory cells and loss of cells in islets of 
langerhans in diabetic rats. Teatment with ethanolic 
extract of IS and its fractions reduced atrophy, 
degenerative changes in pancreatic acini, infiltration of 
inflammatory cells and loss of cells in islets of 
langerhans. Histological studies of liver of the diabetic 
rats revealed that the ethanolic extract of IS and its 
fractions significantly reduced hypertrophy of 
hepatocytes, hepatocellular necrosis and vacuolization 
with loss of nuclei. The kidney histological exposed 
improved architecture with intact tubules and glomeruli 
in the diabetic rats treated with ethanolic extract of IS 
its fractions. It has been reported in our previous study 
that Ipomoea staphylina leaves are rich in phenolic and 
flavonoid content [23].
 
Phenolic compounds and 
flavonoids are known for hypoglycaemic and 
antioxidant properties [24]. Thus, the antidiabetic 
potential of the Ipomoea staphylina leaves may be due 
to the presence of phenolic compounds and flavonoids.  
 
Conclusion 
 
This study shows that the ethanolic extract of IS leaves 
and its fractions has beneficial effects on STZ-
nicotinamde induced type-II diabetes in rats. The 
extract and its fractions improved the blood glucose 
level and restored the altered total cholesterol, 
triglycerides, serum enzymes (SGOT, SGPT and ALP), 
total protein levels. It also enhanced the activities of 
endogenous antioxidant enzymes SOD, CAT and GPx 
in the liver and kidneys. The ethanolic extract of IS 
leaves and its ethyl acetate fraction have shown more 
significant effect on STZ induced diabetic in mice than 
the n-butanol fraction. Thus, further studies are needed 
to explore the antidiabetic mechanisms of ethanolic 
extract and its ethyl acetate fraction of IS leaves.  
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